| Product Code: ETC12953784 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Multiple Sclerosis Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Multiple Sclerosis Market - Industry Life Cycle |
3.4 Afghanistan Multiple Sclerosis Market - Porter's Five Forces |
3.5 Afghanistan Multiple Sclerosis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Afghanistan Multiple Sclerosis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Afghanistan Multiple Sclerosis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Afghanistan Multiple Sclerosis Market Revenues & Volume Share, By Symptom Management, 2021 & 2031F |
3.9 Afghanistan Multiple Sclerosis Market Revenues & Volume Share, By Stage, 2021 & 2031F |
4 Afghanistan Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis in Afghanistan |
4.2.2 Rising healthcare infrastructure and facilities in the country |
4.2.3 Growing access to advanced treatment options for multiple sclerosis patients |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals in the field of multiple sclerosis |
4.3.2 Challenges in accessing and affording expensive multiple sclerosis medications |
4.3.3 Lack of comprehensive data and research on multiple sclerosis prevalence and treatment outcomes in Afghanistan |
5 Afghanistan Multiple Sclerosis Market Trends |
6 Afghanistan Multiple Sclerosis Market, By Types |
6.1 Afghanistan Multiple Sclerosis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Relapsing-Remitting MS, 2021 - 2031F |
6.1.4 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Secondary Progressive MS, 2021 - 2031F |
6.1.5 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Primary Progressive MS, 2021 - 2031F |
6.1.6 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Clinically Isolated Syndrome, 2021 - 2031F |
6.1.7 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Pediatric MS, 2021 - 2031F |
6.2 Afghanistan Multiple Sclerosis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, By MRI, 2021 - 2031F |
6.2.3 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Lumbar Puncture, 2021 - 2031F |
6.2.4 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Evoked Potentials, 2021 - 2031F |
6.2.5 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.2.6 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Neurological Exam, 2021 - 2031F |
6.3 Afghanistan Multiple Sclerosis Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.3.3 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.3.4 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.3.5 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Occupational Therapy, 2021 - 2031F |
6.3.6 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Disease-Modifying Therapies, 2021 - 2031F |
6.4 Afghanistan Multiple Sclerosis Market, By Symptom Management |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Fatigue Management, 2021 - 2031F |
6.4.3 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.4 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Muscle Spasticity, 2021 - 2031F |
6.4.5 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Cognitive Therapy, 2021 - 2031F |
6.4.6 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Emotional Support, 2021 - 2031F |
6.5 Afghanistan Multiple Sclerosis Market, By Stage |
6.5.1 Overview and Analysis |
6.5.2 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Early Stage, 2021 - 2031F |
6.5.3 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Progressive Stage, 2021 - 2031F |
6.5.4 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Advanced Stage, 2021 - 2031F |
6.5.5 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Late Stage, 2021 - 2031F |
6.5.6 Afghanistan Multiple Sclerosis Market Revenues & Volume, By Pediatric Stage, 2021 - 2031F |
7 Afghanistan Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 Afghanistan Multiple Sclerosis Market Export to Major Countries |
7.2 Afghanistan Multiple Sclerosis Market Imports from Major Countries |
8 Afghanistan Multiple Sclerosis Market Key Performance Indicators |
8.1 Number of healthcare facilities offering multiple sclerosis diagnosis and treatment |
8.2 Percentage of multiple sclerosis patients receiving timely and appropriate care |
8.3 Rate of adoption of new and advanced treatment modalities for multiple sclerosis in Afghanistan |
9 Afghanistan Multiple Sclerosis Market - Opportunity Assessment |
9.1 Afghanistan Multiple Sclerosis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Afghanistan Multiple Sclerosis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Afghanistan Multiple Sclerosis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Afghanistan Multiple Sclerosis Market Opportunity Assessment, By Symptom Management, 2021 & 2031F |
9.5 Afghanistan Multiple Sclerosis Market Opportunity Assessment, By Stage, 2021 & 2031F |
10 Afghanistan Multiple Sclerosis Market - Competitive Landscape |
10.1 Afghanistan Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here